Key Takeaway
After 1 year on semaglutide, most patients lose 28 to 45 pounds, reaching near-maximum weight loss. Here is a full 12-month timeline with STEP trial data.
One year on semaglutide is the benchmark that clinical trials use to measure long-term success, and the results at this milestone are striking. Patients researching semaglutide results after 1 year can expect a total weight loss of 28 to 45 pounds, representing roughly 12% to 17% of starting body weight . At this point, most patients have reached or are very close to their maximum weight loss on the medication.
One-Year Results: The Full Picture
| Outcome | Typical Range at 1 Year |
|---|---|
| Total weight loss | 28 to 45 pounds |
| Body weight percentage lost | 12% to 17% |
| Waist circumference | 5 to 8 inches lost |
| Systolic blood pressure | 8 to 16 mmHg decrease |
| A1C (diabetic patients) | 1.2% to 2.2% decrease |
| Triglycerides | 20% to 35% decrease |
| LDL cholesterol | 5% to 15% decrease |
| CRP (inflammation) | 30% to 55% decrease |
The STEP 1 trial[1] reported 14.9% body weight[1] loss at 68 weeks (approximately 15.5 months) on semaglutide 2.4 mg . At the one-year mark (52 weeks), most patients had achieved approximately 13% to 14% loss, with modest additional loss continuing through the end of the study.
The 12-Month process in Review
| Phase | Months | What Happened |
|---|---|---|
| Titration | 1 to 4 | Gradual dose increase from 0.25 to 1.7 mg. Lost 12 to 20 lbs. |
| Peak velocity | 5 to 8 | Full dose (2.4 mg). Fastest weight loss. Lost additional 10 to 18 lbs. |
| Deceleration | 9 to 11 | Weight loss slowed. Lost additional 4 to 8 lbs. |
| Stabilization | 12 | Weight approaching new baseline. Focus shifts to maintenance. |
The entire trajectory follows a predictable logarithmic curve: rapid initial loss that gradually decelerates until a new equilibrium is reached. This isn't treatment failure. It's your body finding a new, healthier weight . For a complete cost breakdown, see our compare GLP-1 providers.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
Health Transformation at One Year
Twelve months of semaglutide therapy produces improvements that extend far beyond the scale:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Cardiovascular: The SELECT trial[2] proved semaglutide reduces heart attacks, strokes, and cardiovascular death by 20%. Your improved blood pressure and lipids contribute to this protection .
- Diabetes prevention: The STEP 1 trial showed that 84% of patients with prediabetes at baseline had normal blood sugar at one year. Semaglutide effectively prevents progression to type 2 diabetes .
- Liver health: Non-alcoholic fatty liver disease improves substantially, with many patients showing normal liver enzyme levels.
- Joint and mobility: Reduced load on joints means less pain, better function, and more active living.
- Mental health: Most patients report improved quality of life scores, better body image, and reduced food-related anxiety.
The Maintenance Question
At one year, the central question becomes: what happens next?
- Continue at 2.4 mg: For patients still losing weight or who want maximum weight maintenance support.
- Reduce to a lower maintenance dose: Some patients maintain at 1.0 or 1.7 mg, saving money and reducing side effects.
- Discontinue with monitoring: Possible but associated with significant weight regain. The STEP 1 extension study showed patients regained about two-thirds of lost weight within a year of stopping .
- Switch to compounded semaglutide: Cost-effective for long-term maintenance FormBlends pricing.
Side Effects and Monitoring at One Year
At one year, semaglutide is well-tolerated by the vast majority of patients who made it this far :
- GI effects: importantly resolved at stable doses.
- Nutritional monitoring: Critical. A full year of reduced intake requires regular testing for vitamin and mineral deficiencies.
- Bone density: Consider a DEXA scan, especially for postmenopausal women.
- Muscle mass: Body composition testing reveals whether lean mass preservation strategies have been effective.
- Psychological wellbeing: The emotional process of a 30+ pound loss over a year deserves attention and support.
Strategies for Year Two and Beyond
- thorough annual health assessment. Full metabolic panel, lipids, CBC, vitamins, minerals, thyroid, and body composition.
- Exercise evolution. Focus on strength, endurance, and functional fitness. Your body is capable of much more than when you started.
- Nutritional improvement. Work with a dietitian to build sustainable eating patterns for your new body weight.
- Maintenance dose discussion. Explore whether a lower dose can maintain your results.
- Community and support. Stay connected with your care team and peer support networks FormBlends telehealth consultation.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
Is 28 to 45 pounds at one year the maximum I can lose on semaglutide?
Most patients reach near-maximum weight loss between months 12 and 15. Some continue to lose small amounts through month 18. The total depends on your dose, starting weight, and lifestyle factors .
What percentage of patients reach 10% or more weight loss at one year?
In the STEP 1 trial, approximately 70% of patients on semaglutide 2.4 mg achieved at least 10% body weight loss, and about 50% achieved 15% or more .
Do I need semaglutide forever?
Not necessarily, but evidence strongly suggests that weight regain is common after stopping. Many experts view obesity as a chronic condition requiring ongoing treatment, similar to blood pressure medication .
Can I switch to tirzepatide after a year on semaglutide?
Yes. If you want additional weight loss or have plateaued, tirzepatide may provide further results. Your provider can manage the transition semaglutide vs tirzepatide comparison.
How do one-year semaglutide results compare to bariatric surgery?
Semaglutide at 2.4 mg produces about 15% total body weight loss on average, compared to 25% to 35% for surgical options like gastric sleeve or bypass. But semaglutide avoids surgical risks, is reversible, and has proven cardiovascular benefits .